Study isolates biosurfactant-producing lactobacillus strain from PCV2-infected piglets, revealing antimicrobial potential.
Lactobacillus salivarius (L. salivarius) is a probiotic widely colonized in the gastrointestinal tracts of humans and animals. Its biosurfactant (BS) exhibits antibacterial and antiviral activities, along with advantages such as biodegradability, non-toxicity, and stability. Porcine circovirus type 2 (PCV2) is a major pathogen in swine farms, causing immunosuppression or immune dysfunction. PCV2-positive herds exhibit elevated susceptibility, often accompanied by severe secondary bacterial infections. To explore novel antimicrobial biologics for enhancing swine immunity, this study isolated a biosurfactant-producing Lactobacillus strain from the intestines of PCV2-infected piglets using the calcium carbonate plate method, and analyzed the anti-microbial activity of the biosurfactant. A strain of biosurfactant-producing L. salivarius was successfully isolated from the ileum of PCV2-infected piglets. The extracted BS from the isolate demonstrated surface tension-reducing properties, forming spreading zones or dispersions on vegetable oil. The antimicrobial experiment showed that at the concentrations of 1.56 - 50 mg/mL, BS inhibited the growth of porcine E. coli and S. suis by 46.01% - 95.06% and 41.06% - 81.64%, respectively. Furthermore, BS of 6.25-12.5 mg/mL significantly inhibited PCV2 replication in PK-15 cells. These findings suggest that L. salivarius is a promising probiotic candidate for improving swine immune status and developing novel alternatives to conventional antimicrobial agents.
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: